Central nicotinic receptor ligands and pharmacophores

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 103-114

  Glennon, Richard A ^a   Dukat, Małgorzata ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

A 84543; A 85380; ABT 089; ABT 418; ABT 594; Aminoethoxypyridines; Anabaseine; Anabasine; Chloronicotine, 6 ; Cotinine; Cytisine; Dihydro erythroidine; DMXB; Epibatidine; GTS 21; Isonicotine; Lobelanidine; Lobelanine; Lobeline; Metanicotine; Myosmine; Nicotine; Nicotinoids; Nornicotine; SIB 1508Y; SIB 1553A; SIB 1765F; Tetrahydropyrido 3,4 d azepines

Indexed keywords

2 METHYL 3 (2 PYRROLIDINYLMETHOXY)PYRIDINE; 3 (2 AZETIDINYLMETHOXY)PYRIDINE; 3 AMINOMETHYLPYRIDINE DERIVATIVE; 3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE; 3 ETHYNYL 5 (1 METHYL 2 PYRROLIDINYL)PYRIDINE FUMARATE; 3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 4 [[2 (1 METHYL 2 PYRROLIDINYL)ETHYL]THIO]PHENOL; 5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE; A 84543; ANABASEINE; ANABASINE; ANABASINE DERIVATIVE; AZEPINE DERIVATIVE; COTININE; CYTISINE; EPIBATIDINE; ISONICOTINE; LOBELANIDINE; LOBELANINE; LOBELINE; MYOSMINE; NICOTINE; NICOTINE DERIVATIVE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NORNICOTINE; PYRIDINE DERIVATIVE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; DRUG DEVELOPMENT; DRUG RECEPTOR BINDING; ENANTIOMER; HUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHOLINERGIC AGENTS; HUMANS; LIGANDS; RECEPTORS, NICOTINIC;

EID: 0034078072     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00022-9     Document Type: Conference Paper

References (61)

1. 3H -labelled azetidine analogue of nicotine Biochem. Pharmacol. 36:1987;2337-2341.
2. Abood L.G., Shahid K.S., Maiti A. Structure-activity studies of carbamate and other esters: agonists and antagonists to nicotine. Pharmacol. Biochem. Behav. 30:1988;403-408.
3. Abreo M.A., Lin N.-H., Garvey D.S., Gunn D.E., Hettinger A.-M., Wasicak J.T., Pavlik P.A., Martin Y.C., Donnelly-Roberts D.L., Anderson D.J., Sullivan J.P., Williams M., Arneric S.P., Holladay M.W. Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. J. Med. Chem. 39:1996;817-825.
4. 3H ]methylcarbamylcholine in rat brain Eur. J. Pharmacol. 252:1994;261-267.
5. Arneric, S., Brioni, J.D. (Eds.), 1999. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. Wiley-Liss, New York.
6. Badio B., Garraffo H.M., Spande T.F., Daly J.W. Epibatidine: discovery and definition as a potent analgesic and nicotinic agonist. Med. Chem. Res. 4:1994;440-448.
7. Barlocco D., Cignarella G., Tondi D., Vianello P., Villa S., Bartolini A., Ghelardini C., Galeotti N., Anderson D.J., Kuntzweiler T.A., Colombo D., Toma L. Mono- and disubstituted 3,8-diazabicyclo[3.2.1]octane derivatives as analgesic structurally related to epibatidine: synthesis, activity and modeling. J. Med. Chem. 41:1998;674-681.
8. Barlow R.B., Johnson O. Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds. Br. J. Pharmacol. 98:1989;799-808.
9. Beers W.H., Reich E. Structure and activity of acetylcholine. Nature. 225:1970;917-922.
10. Bencherif M., Lovette M.E., Fowler K.W., Arrington S., Reeves L., Caldwell W.S., Lippiello P.M. RJR-2403: a nicotinic agonist with CNS selectivity: I. In vitro characterization. J. Pharmacol. Exp. Ther. 279:1996;1413-1421.
11. Bencherif M., Schmitt J.D., Bhatti B.S., Crooks P., Caldwell W.S., Lovette M.E., Fowler K., Reeves L., Lippiello P.M. The heterocyclic substituted pyridine derivative(±)2-(3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 284:1998;886-894.
12. Brioni J.D., Decker M.W., Sullivan J.P., Arneric S.P. The pharmacology of (-)nicotine and novel cholinergic channel modulators. Adv. Pharmacol. 37:1997;153-214.
13. Broka C.A. Synthetic approaches to epibatidine. Med. Chem. Res. 4:1994;449-460.
14. Caldwell, W.S., Benchenif, M., Bhatti, B.S., Deo, N.M., Dobson, G.P., Dull, G.M., Lipiello, P.M., Lovette, M.E., Miller, C.H., Ravard, A., Schmitt, J.D., Crooks, P.A., 1997. Synthesis and structure-activity relationships of analogs of RJR-2403, a CNS-selective nicotinic agonist. Abstracts of International Business Communications Symposium on Nicotinic Acetylcholine Receptors as Pharmaceutical Targets, Washington, DC, July 24-25.
15. Cheng Y.X., Fiedler W., Dukat M., Damaj I., Martin B., Glennon R.A. Conformationally-restricted aminomethylpyridine derivatives as novel nicotinic receptor ligands. Va. J. Sci. 46:1995;135.
16. Cheng Y.X., Dukat M., Dowd M., Fiedler W., Martin B., Damaj M.I., Glennon R.A. Synthesis and binding of 6,7,8,9-tetrahydro-5H-pyrido[3,4-d]azepine and related ring-open analogs at central nicotinic receptors. Eur. J. Med. Chem. 34:1999;177-190.
17. 3H ]nicotine binding in rat striatum. Abstracts, College on Problems of Drug Dependence meeting, Acapulco, Mexico, June 12-17, 1999, p. 29.
18. Damaj M.I., Patrick G.S., Creasy K.R., Martin B.R. Pharmacology of lobeline, a nicotinic receptor ligand. J. Pharmacol. Exp. Ther. 282:1997;410-419.
19. 125I ]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors J. Pharmacol. Exp. Ther. 282:1997;445-451.
20. 125I -α-bungarotoxin receptor subtypes Mol. Pharmacol. 47:1995;164-171.
21. Dolle F., Dolci L., Valette H., Hinnen F., Vaufrey F., Guenther I., Fuseau C., Coulon C., Bottaender M., Crouzel C. Synthesis and nicotinic acetylcholinergic receptor in vivo binding properties of 2-fluoro-3-[2(s)-2-azetidinylmethoxy]pyridine: a new positron emission tomography ligand for nicotinic receptors. J. Med. Chem. 42:1999;2251-2259.
22. Dukat M. 208/210 a.k.a. Epibatidine. Med. Chem. Res. 4:1994;433-439. and following articles.
23. Dukat M., Damaj M.I., Glassco W., Dumas D., May E.L., Martin B.R., Glennon R.A. Epibatidine: a very high affinity nicotine-receptor ligand. Med. Chem. Res. 4:1994;131-139.
24. Dukat M., Fiedler W., Dumas D., Damaj I., Martin B.R., Rosecrans J.A., James J.R., Glennon R.A. Pyrrolidine-modified and 6-substituted analogs of nicotine: a structure-affinity investigation. Eur. J. Med. Chem. 31:1996;875-888.
25. Dukat M., Dowd M., Damaj I.M., Martin B., El-Zahabi M., Glennon R.A. Synthesis, receptor binding and QSAR studies on 6-substituted nicotine derivatives as cholinergic ligands. Eur. J. Med. Chem. 34:1999;31-40.
26. Dukat, M., Flammia, D.D., Damaj, M.I., Martin, B., Glennon, R.A., 1999b. Lobeline: a nicotine receptor structure-affinity study. Abstracts, College on Problems of Drug Dependence meeting, Acapulco, Mexico, June 12-17, 1999, p. 37.
27. Dwoskin, L., 1999. Novel subtype selective nicotinic receptor antagonists block the neurochemical effects of nicotine. Presented at College on Problems of Drug Dependence meeting, Acapulco, Mexico, June 12-17, 1999.
28. Elliott R.L., Ryther K.B., Anderson D.J., Piattoni-Kaplan M., Kuntzweiler T., Donnelly-Roberts D., Arneric S.P., Holladay M.W. Novel 2-(2′-furo[3,2-b]pyridinylpyrrolidines: potent neuronal nicotinic acetylcholine receptor ligands. Bioorg. Med. Chem. Lett. 7:1997;2703-2708.
29. Flammia, D.D., Dukat, M., Damaj, M.I., Martin, B.R., Glennon, R.A., 1999. Lobeline: failure to meet Sheridan pharmacophore requirements. Virginia Academy of Sciences meeting, Norfork, VA, May 25-28, 1999.
30. Fujita T., Nakajima M., Soeda Y., Yamamoto I. Physicochemical properties of biological interest of nicotine and its related compounds. Pestic. Biochem. Physiol. 1:1971;151-162.
31. Glaser, R., Hug, P., Drouin, M., Michel, A., 1992. Solution- and solid-state stereochemistry of (-)α-lobeline hydrochloride and hydrobromide, a respiratory stimulant. J. Chem. Soc. Perkin Trans., pp. 1071-1079.
32. Glassco W., Suchocki J., George C., Martin B.R., May E.L. Synthesis, optical resolution, absolute configuration and preliminary pharmacology of (+)- and (-)cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo[3,2-h]isoquinoline, a structural analog of nicotine. J. Med. Chem. 36:1993;3381-3385.
33. Glennon R.A., Dukat M. Nicotinic receptor ligands. Med. Chem. Res. 6:1996;465-486.
34. Glennon, R.A., Dukat, M., 1999a. Nicotinic cholinergic receptor pharmacophores. In: Arneric, S.P., Brioni, J.D. (Eds.), Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. Wiley-Liss, New York, pp. 271-284.
35. Glennon, R.A., Dukat, M., 1999b. Nicotine analogs: structure-affinity relationships for central acetyl-cholinergic receptor binding. In: Yamamoto, I., Casida, J.E. (Eds.), Nicotinoid Insecticides and the Nicotinic Acetylcholine Receptor. Spinger-Verlag, Tokyo, 237-252.
36. Glennon R.A., Herndon J.L., Dukat M. Epibatidine-aided studies toward definition of a nicotinic receptor pharmacophore. Med. Chem. Res. 4:1994;461-473.
37. Gotti C., Balestra B., Moretti M., Rovati G.E., Maggi L., Rossoni G., Berti F., Villa L., Pallavicini M., Clementi F. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic α-bungarotoxin receptors. Br. J. Pharmacol. 124:1998;1197-1206.
38. Holladay M.W., Dart M.J., Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40:1997;4169-4194.
39. Holladay M.W., Wasicak J.T., Lin N.-H., Ryther K.B., Bannon A.W., Buckley M.J., Kim D.J.B., Decker M.W., Anderson D.J., Campbell J.E., Kuntzweiler T.A., Donnelly-Roberts D.L., Piattoni-Kaplan M., Briggs C.A., Williams M., Arneric S.P. Identification and initial structure-activity relationships of (R)-5-(2-Azetidinylmethoxy)-2-chlorpyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors. J. Med. Chem. 41:1998;407-412.
40. Holladay, M.W., Cosford, N.D.P., McDonald, I.A., 1999. Natural products as a source of nicotinic acetylcholine receptor modulators and leads for drug discovery. In: Arneric, S.P., Brioni, J.D. (Eds.), Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. Wiley-Liss, New York, pp. 253-270.
41. 11C ]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors J. Med. Chem. 41:1998;4199-4206.
42. 3H ]Epibatidine binding to nicotinic cholinergic receptors in brain Med. Chem. Res. 4:1994;538-546.
43. Koren A.O., Horti A.G., Mukhin A.G., Gundisch D., Kimes A.S., Dannals R.F., London E.D. 2-, 5- and 5-Halo-3-(2(S)azetidinylmethoxy)pyridines: synthesis, affinity for nicotinic acetylcholine receptors and molecular modeling. J. Med. Chem. 41:1998;3690-3698.
44. 2 neuronal nicotinic acetylcholine receptor. J. Med. Chem. 42:1999;2227-2234.
45. Lin N.-H., Carrera G.M., Anderson D.J. Synthesis and evaluation of nicotine analogs as neuronal nicotinic acetylcholine receptor ligands. J. Med. Chem. 37:1994;3542-3553.
46. Lin N.-H., Gunn D.E., Ryther K.B., Garvey D.S., Donnely-Roberts D.L., Decker M.W., Brioni J.D., Buckley M.J., Rodrigues A.D., Marsh K.G., Anderson D.J., Buccafusco J.J., Prendergast M.A., Sullivan J.P., Williams M., Arneric S.P., Holladay M.W. Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties. J. Med. Chem. 40:1997;385-390.
47. Lin N.-H., Gunn D.E., Li Y., He Y., Bai H., Ryther K.B., Kuntzweiler T., Donnelly-Roberts D.L., Anderson D.J., Campbell J.E., Sulivan J.P., Arneric S.P., Holladay M.W. Synthesis and structure-activity relationships of pyridine-modified analogues of 3-[2-(S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist. Bioorg. Med. Chem. Lett. 8:1998;249-254.
48. McDonald I.A., Cosford N., Vemier J.-M. Nicotinic acetylcholine receptors: molecular biology, chemistry and pharmacology. Annu. Rep. Med. Chem. 30:1995;41-50.
49. Meyer E.M., Tay E.T., Zoltewicz J.A., King M.A., Papke R.L., de Fiebre C.M. Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties. J. Pharmacol. Exp. Ther. 284:1998;1026-1032.
50. Meyer E.M., Juryatov A., Gerzanich V., Lindstrom J., Papke R.L. Analysis of 3-(4-hydroxy, 2-methoxybenzylidine)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors. J. Pharmacol. Exp. Ther. 287:1998;918-925.
51. Olesen P.H., Swedberg M.D.B., Eskesen K., Judge M.E., Egebjerg J., Tonder J.E., Rasmussen T., Sheardown M.J., Rimvall K. Identification of novel (isoxazole)methylene-1-azabicyclic compounds with high affinity for the central nicotinic cholinergic receptor. Bioorg. Med. Chem. Lett. 7:1997;1963-1968.
52. Qian C., Li T., Shen T.Y., Libertine-Garahan L., Eckman J., Biftu T., Ip S. Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250:1993;R13-R14.
53. Rosecrans J.A., Brioni J.D. Medicinal chemistry and pharmacology of neuronal nicotinic receptors. Med. Chem. Res. 6:1996;439-443. and following articles.
54. Sacaan A.I., Reid R.T., Santori E.M., Adams P., Correa L.D., Mahaffy L.S., Bleicher L., Cosford N.D.P., Stauderman K.A., McDonald I.A., Rao T.S., Lloyd G.K. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J. Pharmacol. Exp. Ther. 280:1997;373-383.
55. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:1993;403-443.
56. Shacka J.J., Robinson S.E. Central and peripheral anatomy of nicotinic sites. Med. Chem. Res. 6:1996;444-464.
57. Sheridan R.P., Nilakantan R., Dixon J.S., Venkataraghavan R. The ensemble approach to distance geometry: application to the nicotinic pharmacophore. J. Med. Chem. 29:1986;899-906.
58. Vernier J.-M., Holsenback H., Cosford N.D.P., Whitten J.P., Menzaghi F., Reid R., Rao T.S., Sacaan A.I., Lloyd G.K., Suto C.M., Chavez-Noriega L.E., Washburn M.S., Urrutia A., McDonald I.A. Conformationally restricted analogues of nicotine and anabasine. Bioorg. Med. Chem. Lett. 8:1998;2173-2178.
59. Vernier J.-M., El-Abdellaouri H., Holsenback H., Cosford N.D.P., Bleicher L., Barker G., Bontempi B., Chavez-Noriega L., Menzaghi F., Rao T.S., Teid R., Sacaan A.I., Suto C., Washburn M., Lloyd G.K., McDonald I.A. 4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors. J. Med. Chem. 42:1999;1684-1686.
60. Yamamoto, I., 1965. Nicotinoids as insecticides. In: Metcalf, R.L. (Ed.), Advances in Pest Control Research. Wiley-Interscience, New York, pp. 231-260.
61. Yamamoto, I., Casida, J.E. (Eds.), 1999. Nicotinoid Insecticides and the Nicotinic Acetylcholine Receptor. Spinger-Verlag, Tokyo.